Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of Johnson Matthey (LON:JMAT – Free Report) in a report published on Monday morning,Digital Look reports. Deutsche Bank Aktiengesellschaft currently has a GBX 2,400 price objective on the stock.
Other equities analysts also recently issued research reports about the company. UBS Group reaffirmed a “neutral” rating and issued a GBX 2,200 target price on shares of Johnson Matthey in a research report on Friday, May 22nd. Jefferies Financial Group restated a “restricted” rating on shares of Johnson Matthey in a research note on Friday, May 29th. Finally, Berenberg Bank upped their price objective on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a report on Monday, June 1st. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Johnson Matthey has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,298.33.
View Our Latest Research Report on JMAT
Johnson Matthey Stock Performance
Johnson Matthey (LON:JMAT – Get Free Report) last announced its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 EPS for the quarter. The business had revenue of GBX 1,257.30 billion for the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. On average, sell-side analysts anticipate that Johnson Matthey will post 173.4112903 EPS for the current year.
Insider Buying and Selling
In related news, insider Liam Condon bought 4,500 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was acquired at an average cost of GBX 2,127 per share, with a total value of £95,715. Also, insider Richard Pike purchased 14 shares of Johnson Matthey stock in a transaction on Wednesday, June 10th. The stock was bought at an average price of GBX 1,990 per share, for a total transaction of £278.60. Over the last three months, insiders have acquired 11,470 shares of company stock valued at $24,671,344. Company insiders own 0.51% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
- 2 Short Squeezes for Summer Speculation: What the Bears Are Getting Wrong
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
